BARBARA PEREZ-GUEVARA: Open Payments
NPI 1043728371 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 58 payments from 17 companies in 2025. Trend: 2023 $1,233 · 2024 $1,449 · 2025 $1,688
Food & beverage: $1,688
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $252 |
| Novo Nordisk Inc | 14 | $250 |
| AstraZeneca Pharmaceuticals LP | 3 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $190 |
| Lilly USA, LLC | 4 | $175 |
| Insulet Corporation | 5 | $171 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| SI-BONE, INC. | 1 | $92 |
| Amgen Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $37 |
Products named: Kerendia, Omnipod, VRAYLAR, KISUNLA, BREZTRI, Auvelity, UBRELVY, Wegovy.
Industry payments across TX — which companies pay providers there.
